Literature DB >> 29734055

Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.

Allison M Garrison1, Jennifer M Parrott1, Arnulfo Tuñon1, Jennifer Delgado1, Laney Redus1, Jason C O'Connor2.   

Abstract

Chronic stress or inflammation increases tryptophan metabolism along the kynurenine pathway (KP), and the generation of neuroactive kynurenine metabolites contributes to subsequent depressive-like behaviors. Microglia regulate KP balance by preferentially producing oxidative metabolites, including quinolinic acid. Research has focused on the interplay between cytokines and HPA axis-derived corticosteroids in regulating microglial activity and effects of KP metabolites directly on neurons; however, the potential role that KP metabolites have directly on microglial activity is unknown. Here, murine microglia were stimulated with lipopolysaccharide(LPS). After 6 h, mRNA expression of interleukin(IL)-1β, IL-6, tumor necrosis factor(TNF)-α and inducible nitric oxide synthase(iNOS) was dose-dependently increased along with the rate-limiting enzymes for oxidative KP metabolism, indoleamine-2,3-dioxygenase(IDO)-1 and kynurenine 3-monooxygenase(KMO). By 24 h post-LPS, kynurenine and quinolinic acid in the media was elevated. Inhibiting KMO with Ro 61-8048 during LPS challenge attenuated extracellular nitrite accumulation and expression of KMO and TNF-α in response to LPS. Similarly, primary microglia isolated from KMO-/- mice exhibited a significantly reduced pro-inflammatory response to LPS compared to WT controls. To determine whether the substrate (kynurenine) or end product (quinolinic acid) of KMO-dependent metabolism modulates the LPS response, microglia were treated with increasing concentrations of L-kynurenine or quinolinic acid in combination with LPS or saline. Interestingly, quinolinic acid did not impact the microglial LPS response. However, L-kynurenine had dose-dependent inhibitory effect on the LPS response. These data are the first to show an anti-inflammatory effect of KMO inhibition on microglia during immune challenge and suggest that KP metabolic balance may play a direct role in regulating microglia activity. Published by Elsevier Ltd.

Entities:  

Keywords:  Cytokines; Inflammation; Kynurenine metabolism; Microglia

Mesh:

Substances:

Year:  2018        PMID: 29734055      PMCID: PMC5995655          DOI: 10.1016/j.psyneuen.2018.04.019

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  49 in total

1.  The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.

Authors:  Anja Henn; Søren Lund; Maj Hedtjärn; Andreé Schrattenholz; Peter Pörzgen; Marcel Leist
Journal:  ALTEX       Date:  2009       Impact factor: 6.043

2.  Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

Authors:  E Blasi; R Barluzzi; V Bocchini; R Mazzolla; F Bistoni
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

3.  Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory.

Authors:  Jillian M Heisler; Jason C O'Connor
Journal:  Brain Behav Immun       Date:  2015-06-27       Impact factor: 7.217

4.  RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.

Authors:  Christoph F A Vogel; Eric Sciullo; Wen Li; Pat Wong; Gwendal Lazennec; Fumio Matsumura
Journal:  Mol Endocrinol       Date:  2007-09-06

5.  Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

Authors:  Thomas J Connor; Neasa Starr; Joan B O'Sullivan; Andrew Harkin
Journal:  Neurosci Lett       Date:  2008-06-07       Impact factor: 3.046

6.  Neurotransmitter signaling in the pathophysiology of microglia.

Authors:  María Domercq; Nuria Vázquez-Villoldo; Carlos Matute
Journal:  Front Cell Neurosci       Date:  2013-04-19       Impact factor: 5.505

7.  Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.

Authors:  Jennifer M Parrott; Laney Redus; Jason C O'Connor
Journal:  J Neuroinflammation       Date:  2016-05-27       Impact factor: 8.322

8.  Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice.

Authors:  Carlos R Dostal; Megan Carson Sulzer; Keith W Kelley; Gregory G Freund; Robert H McCusker
Journal:  Neurobiol Stress       Date:  2017-02-12

9.  Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.

Authors:  Jean Rodgers; Trevor W Stone; Michael P Barrett; Barbara Bradley; Peter G E Kennedy
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

Review 10.  Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology.

Authors:  Jennifer M Parrott; Jason C O'Connor
Journal:  Front Psychiatry       Date:  2015-08-20       Impact factor: 4.157

View more
  24 in total

1.  Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling.

Authors:  Ning Ma; Ting He; Lee J Johnston; Xi Ma
Journal:  Gut Microbes       Date:  2020-05-13

Review 2.  Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.

Authors:  Jing-Ru Liu; Hua Miao; De-Qiang Deng; Nosratola D Vaziri; Ping Li; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2020-09-23       Impact factor: 9.261

3.  Brain derived neurotrophic factor deficiency exacerbates inflammation-induced anhedonia in mice.

Authors:  Jennifer M Parrott; Grace A Porter; Laney Redus; Jason C O'Connor
Journal:  Psychoneuroendocrinology       Date:  2021-09-20       Impact factor: 4.905

4.  Blast Preconditioning Protects Retinal Ganglion Cells and Reveals Targets for Prevention of Neurodegeneration Following Blast-Mediated Traumatic Brian Injury.

Authors:  Matthew M Harper; Addison W Woll; Lucy P Evans; Michael Delcau; Abhigna Akurathi; Adam Hedberg-Buenz; Dana A Soukup; Nickolas Boehme; Marco M Hefti; Laura M Dutca; Michael G Anderson; Alexander G Bassuk
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

Review 5.  The kynurenine pathway: a finger in every pie.

Authors:  Jonathan Savitz
Journal:  Mol Psychiatry       Date:  2019-04-12       Impact factor: 15.992

6.  Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.

Authors:  Kaat Hebbrecht; Katrien Skorobogatov; Erik J Giltay; Violette Coppens; Livia De Picker; Manuel Morrens
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 7.  Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression.

Authors:  Ferenc Zádor; Sâmia Joca; Gábor Nagy-Grócz; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Sándor Benyhe; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 8.  Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review.

Authors:  Evangelos Karanikas; Nikolaos P Daskalakis; Agorastos Agorastos
Journal:  Brain Sci       Date:  2021-05-29

9.  Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.

Authors:  Ruo-Nan Duan; Chun-Lin Yang; Tong Du; Ai Liu; An-Ran Wang; Wen-Jie Sun; Xi Li; Jiang-Xia Li; Chuan-Zhu Yan; Qi-Ji Liu
Journal:  J Neuroinflammation       Date:  2021-06-28       Impact factor: 8.322

Review 10.  The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Authors:  Maryam Assem; Mathilde Lando; Maria Grissi; Saïd Kamel; Ziad A Massy; Jean-Marc Chillon; Lucie Hénaut
Journal:  Toxins (Basel)       Date:  2018-07-22       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.